Optimize Practice of Central Precocious Puberty (CPP)
Vargas Trujillo CPP Study Review: Overview and Baseline Characteristics
Vargas Trujillo CPP Study Review: Study Results
Vargas Trujillo CPP Study Review: Conclusion
Individualizing Treatment Decisions in Girls With Central Precocious Puberty
CPP Patient Case: When to Treat
CPP Patient Case: When to Stop Treatment
Karen O. Klein, MD, provides an overview of CPP (central precocious puberty) as well as a review of the study design and baseline characteristics from the Vargas Trujillo et al study on the importance of individualizing treatment decisions in girls with CPP.
Meet the Speakers
Karen O. Klein, M.D.
Pediatric Endocrinologist,
Rady Children’s Hospital - San Diego
Clinical Professor of Pediatrics
UC San Diego School of Medicine
San Diego, CA
Kent L. Reifschneider, M.D.
Pediatric Endocrinologist,
School Children’s Hospital of The King’s Daughters
Pediatric Endocrinology
Associate Professor at Eastern Virginia Medical
Norfolk, VA
Marcela Vargas Trujillo, M.D.
Pediatric Endocrinologist,
Rady Children’s Hospital - San Diego
Associate Professor
Division of Pediatric Endocrinology
UC San Diego School of Medicine
San Diego, CA
Program Objectives
Discuss diagnosing CPP in girls
Understand treatment strategies
Explore best practices for patient communication
Gain expert insights and statistics on the impact of treatment decisions in CPP
Toolkit with Additional Resource on CPP
"Recognizing the Signs of Central Precocious Puberty (CPP) Earlier: Journey from Patient to Referral Through Case Studies"
https://www.endocrinologynetwork.com/toolkits/cpp
©2022 AbbVie Inc. ABBV-US-01040-MC v2 11/2022